BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24950687)

  • 1. Breast cancer classification: linking molecular mechanisms to disease prognosis.
    Taherian-Fard A; Srihari S; Ragan MA
    Brief Bioinform; 2015 May; 16(3):461-74. PubMed ID: 24950687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disease annotation study of gene signatures in a breast cancer microarray dataset.
    Gypas F; Bei ES; Zervakis M; Sfakianakis S
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():5551-4. PubMed ID: 22255596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic Subtypes of Primary Breast Cancer--Gene Expression Analysis.
    Schmidt M; Thomssen C; Untch M
    Oncol Res Treat; 2016; 39(3):102-10. PubMed ID: 27031354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable Gene Signature Selection for Prediction of Breast Cancer Recurrence Using Joint Mutual Information.
    Sehhati M; Mehridehnavi A; Rabbani H; Pourhossein M
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1440-8. PubMed ID: 26671813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
    Weigelt B; Baehner FL; Reis-Filho JS
    J Pathol; 2010 Jan; 220(2):263-80. PubMed ID: 19927298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomolecular features of clinical relevance in breast cancer.
    Daidone MG; Paradiso A; Gion M; Harbeck N; Sweep F; Schmitt M
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S3-14. PubMed ID: 15095022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
    Chung L; Baxter RC
    Expert Rev Proteomics; 2012 Dec; 9(6):599-614. PubMed ID: 23256671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NETBAGs: a network-based clustering approach with gene signatures for cancer subtyping analysis.
    Wu L; Liu Z; Xu J; Chen M; Fang H; Tong W; Xiao W
    Biomark Med; 2015; 9(11):1053-65. PubMed ID: 26501477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Progression Prediction Using Gene Interaction Regularized Elastic Net.
    Lin Zhang ; Hui Liu ; Yufei Huang ; Xuesong Wang ; Yidong Chen ; Jia Meng
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(1):145-154. PubMed ID: 28055897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.
    Martinez-Ledesma E; Verhaak RG; Treviño V
    Sci Rep; 2015 Jul; 5():11966. PubMed ID: 26202601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfamilial breast cancer subtypes.
    Ringnér M; Staaf J; Jönsson G
    Methods Mol Biol; 2013; 973():279-95. PubMed ID: 23412797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient sample-oriented analysis of gene expression highlights extracellular signatures in breast cancer progression.
    Hong Y; Kim N; Li C; Jeong E; Yoon S
    Biochem Biophys Res Commun; 2017 May; 487(2):307-312. PubMed ID: 28412350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in breast cancer.
    Vivanco Md
    Methods Mol Biol; 2010; 593():137-56. PubMed ID: 19957148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks.
    Gevaert O; De Smet F; Timmerman D; Moreau Y; De Moor B
    Bioinformatics; 2006 Jul; 22(14):e184-90. PubMed ID: 16873470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-driven integrated classification of breast cancer validated in over 7,500 samples.
    Ali HR; Rueda OM; Chin SF; Curtis C; Dunning MJ; Aparicio SA; Caldas C
    Genome Biol; 2014 Aug; 15(8):431. PubMed ID: 25164602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Molecular Profiling and Radiotherapy Considerations.
    Mahmoud O; Haffty BG
    Adv Exp Med Biol; 2016; 882():95-124. PubMed ID: 26987532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.